cagrisema semaglutide cagrilintide phase 3 results 2024 2025 obesity drug: what the data shows Novo Nordisk: Obesity drug CagriSema

Low-dose methotrexate is the most frequent therapy for rheumatoid arthritis

Discovering the low quality of existing products, he crafted his own, mastering the principles of nutraceutical liposomes and creating their flagship Liposomal Glutathione

Wolverine Peptide Blend BPC-157 + TB-500 (10mg & 5mg) A two-peptide regenerative research blend pairing BPC-157 (5 mg) and TB-500 (5 mg), co-lyophilized in a single sterile vial for in-vitro study

Richard Looney and his research team have previously identified bone marrow mesenchymal stem cells (BM-MSC) from patients with systemic lupus erythmatosis (SLE) that exhibit signs of senescence